2025 Sets a Positive Trend for Cyprus Real Estate

by News Editor

April 26, 2025

The real estate market in Cyprus has surged forward in 2025, marking a significant 15% increase in property sales compared to the previous year. This remarkable growth in the first quarter is highlighted by the 4,137 sale documents filed, as per reports from the Registration Council of Real Estate Agents.

While there was a slight decrease of 2.9% in transaction volume, the sales value saw a robust increase of 15%, surpassing €1.1 billion annually. This promising start to the year reflects sustained demand and better alignment of supply to market needs.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Insights from Regional Markets

Limassol continues to dominate the market, boasting the highest value transfer at €428.7 million and leading in documentation volume with 1,295 sale filings. Additionally, the city recorded 1,203 transaction volumes, underscoring strong investment activities.

In Nicosia, stability reigns with 1,304 transactions valued at €283.5 million. The city attracted 932 new sale documents, reflecting keen interest in fresh developments.

The momentum from previous years carries on in Paphos, with 811 transfers totaling €199 million. This shows lively activity in property purchase, fueled chiefly by international buyers.

Larnaca saw €154 million in transactions from 843 property transfers. The sale documents numbered 910, indicating rising demand bolstered by ongoing investments, as featured in Desalination Breakthrough: Addressing Water Shortages in Cyprus.

Though the Famagusta region ranked lowest with €48 million and 251 transfers, the growth trend persists. The 171 sale documents filed signal an appeal through lower prices and tourism-driven development.

The Future Forbes Realty Global Properties

Anthropic Acquires Coefficient Bio In $400 Million Stock Deal

by THEFUTURE.TEAM

April 6, 2026

Anthropic acquired biotech AI startup Coefficient Bio in a deal valued at approximately $400 million in stock, according to people familiar with the matter. Sources confirmed the transaction, although detailed financial terms were not publicly disclosed.

Deepening Forays Into Healthcare And Life Sciences

The acquisition follows Anthropic’s earlier launch of Claude for Life Sciences, a tool designed to support scientific research and drug discovery. The deal expands the company’s activity in healthcare and biotechnology. Anthropic is increasing its focus on applying AI models to scientific workflows, including data analysis and experimental design. Expansion into life sciences reflects broader industry trends.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Transforming Computational Drug Discovery

Coefficient Bio was founded eight months ago by Samuel Stanton and Nathan C. Frey, both former researchers at Genentech’s Prescient Design group. The company focused on applying AI to drug discovery and biological research processes. Its technology aims to improve efficiency in identifying drug candidates and analyzing biological data. Early-stage development reflects growing interest in AI-driven research tools.

Strategic Talent And Expertise Integration

Around 10 employees from Coefficient Bio will join Anthropic following the acquisition, strengthening its health and life sciences team. The group will contribute to the development of AI models for scientific and medical applications. Access to specialized talent supports the expansion of capabilities in drug discovery and biological research.

Industry Context And Outlook

Investment in AI for drug discovery has increased as companies seek to reduce development timelines and costs. Large technology firms and startups are expanding activity in this area. Further developments will depend on how effectively Anthropic integrates the team and advances its life sciences strategy.

Breaking news